Ophthalmological

Central retinal artery occlusion

11

studies recruiting now

as of 7 Sept 2026

53

studies registered in total

as of 7 Sept 2026

5

countries with a recruiting site

as of 7 Sept 2026

22 Apr 2026

most recent study posted

among recruiting studies

Recruiting trials

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 11 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Central retinal artery occlusion study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Central retinal artery occlusion

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Tenecteplase (Metalyse)
Phase 3Aspirin (8-hour bayer)
Phase 3Alteplase (Actilyse)
Phase 2Regadenoson Anhydrous

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).